AU2000261861A1 - Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom - Google Patents
Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefromInfo
- Publication number
- AU2000261861A1 AU2000261861A1 AU2000261861A AU6186100A AU2000261861A1 AU 2000261861 A1 AU2000261861 A1 AU 2000261861A1 AU 2000261861 A AU2000261861 A AU 2000261861A AU 6186100 A AU6186100 A AU 6186100A AU 2000261861 A1 AU2000261861 A1 AU 2000261861A1
- Authority
- AU
- Australia
- Prior art keywords
- hepatitis
- fusion protein
- gene expression
- mass production
- expression system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR2000/000825 WO2002010396A1 (en) | 2000-07-28 | 2000-07-28 | Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000261861A1 true AU2000261861A1 (en) | 2002-02-13 |
Family
ID=19198245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000261861A Abandoned AU2000261861A1 (en) | 2000-07-28 | 2000-07-28 | Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2000261861A1 (en) |
WO (1) | WO2002010396A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015060235A1 (en) * | 2013-10-21 | 2015-04-30 | 大鵬薬品工業株式会社 | Novel four-ctl epitope-joined peptide |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100203919B1 (en) * | 1996-10-04 | 1999-06-15 | 신동권 | A novel expression vector which produces water soluble protein |
-
2000
- 2000-07-28 AU AU2000261861A patent/AU2000261861A1/en not_active Abandoned
- 2000-07-28 WO PCT/KR2000/000825 patent/WO2002010396A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002010396A9 (en) | 2005-04-14 |
WO2002010396A1 (en) | 2002-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002252183A1 (en) | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases | |
AU5579699A (en) | Rapid amperometric verification of pcr amplification of dna | |
AU2003284689A1 (en) | NUCLEIC ACID CONSTRUCT CONTAINING HEPATITIS C VIRUS (HCV) OF GENOCYPE 2a GENOME-ORIGIN NUCLEIC ACID AND CELL HAVING THE NUCLEIC ACID CONSTRUCT TRANSFERRED THEREINTO | |
WO2003031588A3 (en) | Hepatitis c virus vaccine | |
AU2002365912A1 (en) | Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection | |
EP1256628A3 (en) | Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof | |
WO2002006457A3 (en) | Novel lipase genes | |
AU6974496A (en) | Methods of using nucleotide integrase for cleaving dna and attaching nucleic acids | |
WO2003025154A3 (en) | Methods and compositions for the construction and use of fusion libraries | |
AU2001273559A1 (en) | Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids | |
AU2002249967A1 (en) | Gene silencing using sense dna and antisense rna hybrid constructs | |
AU6203700A (en) | Hybridization of target dna with immobilized nucleic acid analogs | |
AU2000261861A1 (en) | Gene expression system for mass production of hepatitis c viral rna-dependent rna polymerase and enzyme assay using fusion protein expressed therefrom | |
IL142288A0 (en) | An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase | |
WO2001068807A3 (en) | Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme | |
AU2003220136A1 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | |
WO2001064912A3 (en) | Triazine degrading enzymes | |
AU2001249245A1 (en) | Identification of in vivo dna binding loci of chromatin proteins using a tethered nucleotide modification enzyme | |
AU2438501A (en) | Expression of proteins from amplified, immobilized nucleic acids | |
AU2405300A (en) | Uses of flavivirus rna-dependent rna polymerases | |
EP1301631A4 (en) | Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins | |
AU8258198A (en) | Separation of nucleic acids by antibodies to halogenated nucleotides | |
AU6235000A (en) | Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids | |
AU2002232586A1 (en) | Novel s. pyogenes dna polymerase iii holoenzyme nucleic acid molecules and proteins | |
AU2001249526A1 (en) | Approaches for hpv detection and staging by targeting the e6 gene region of the viral genome |